about
Consequences of extrahepatic manifestations of hepatitis C viral infection (HCV)Genetic Variability of Hepatitis C Virus (HCV) 5' Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and RibavirinFactors affecting the component community structure of haemoparasites in common voles ( Microtus arvalis) from the Mazury Lake District region of Poland.Factors affecting the component community structure of haemoparasites in bank voles (Clethrionomys glareolus) from the Mazury Lake District region of Poland.Medium-term temporal stability of the helminth component community structure in bank voles (Clethrionomys glareolus) from the Mazury Lake District region of Poland.Analysis of genotype 1b hepatitis C virus IRES in serum and peripheral blood mononuclear cells in patients treated with interferon and ribavirinDetection of hepatitis C virus (HCV) negative strand RNA and NS3 protein in peripheral blood mononuclear cells (PBMC): CD3+, CD14+ and CD19+.Deep sequencing of hepatitis C virus hypervariable region 1 reveals no correlation between genetic heterogeneity and antiviral treatment outcomeThe correlation between pretreatment cytokine expression patterns in peripheral blood mononuclear cells with chronic hepatitis C outcome.Spouse-to-Spouse Transmission and Evolution of Hypervariable Region 1 and 5' Untranslated Region of Hepatitis C Virus Analyzed by Next-Generation SequencingPathogens vectored by the tick, Dermacentor reticulatus, in endemic regions and zones of expansion in Poland.Ultradeep pyrosequencing of hepatitis C virus hypervariable region 1 in quasispecies analysis.Seronegative hepatitis C virus infection.Next-Generation Sequencing of 5' Untranslated Region of Hepatitis C Virus in Search of Minor Viral Variant in a Patient Who Revealed New Genotype While on Antiviral Treatment.Sensitivity of Next-Generation Sequencing Metagenomic Analysis for Detection of RNA and DNA Viruses in Cerebrospinal Fluid: The Confounding Effect of Background Contamination.First report of two asymptomatic cases of human infection with Babesia microti (Franca, 1910) in Poland.Evidence for immune activation in patients with residual hepatitis C virus RNA long after successful treatment with IFN and ribavirin.Seronegative hepatitis C virus infection in patients with lymphoproliferative disorders.Hepatitis C virus 5' untranslated region variability correlates with treatment outcome.Hepatitis G virus/GBV-C in serum, peripheral blood mononuclear cells and bone marrow in patients with hematological malignancies.Erratum to: 'The correlation between pretreatment cytokine expression patterns in peripheral blood mononuclear cells with chronic hepatitis c outcome'.Variability of hepatitis C virus hypervariable region 1 (HVR-1) during the early phase of pegylated interferon and ribavirin therapy.Differential display analysis of gene expression in brains from hepatitis C-infected patients.Corrigendum: Evidence for immune activation in patients with residual hepatitis C virus RNA long after successful treatment with IFN and ribavirin.Corrigendum to: Hepatitis C virus (HCV) infection of peripheral blood mononuclear cells in patients with type II cryoglobulinemia. Hum Immunol. 2013;74(12):1559-62.Next-generation sequencing analysis of a cluster of hepatitis C virus infections in a haematology and oncology center.Diversity of thalassemia variants in Poland - screening by real-time PCR.Molecular identification of tick-borne pathogens in asymptomatic individuals with human immunodeficiency virus type 1 (HIV-1) infection: a retrospective study.
P50
Q26749559-789B289F-7EF8-4AA5-8756-49FC52689B36Q28546960-CACD3DCD-4F5F-4572-B581-E160EC33FA63Q33196655-AC10D8DB-2E5B-4A19-A9AD-C679CAEE2E6CQ33444420-CFEF4326-B165-41B0-9418-2E02F4D945D3Q33448797-893ABAAD-0A5E-45F8-8C56-C19E58210419Q33930405-C80D5474-8D49-4422-947B-74E923CCEFD2Q34465545-577EE575-C047-4957-B684-0784CFE69A3BQ34485144-C56E319E-CB3B-456C-BEE0-DB8FFDF451ECQ35861413-63531803-9A74-437A-B2DC-0C56ACE289C3Q35936933-F911ED60-2998-41F6-8F58-8038D83F185BQ36089075-D8389DD2-9A3F-40D2-AF34-F9D49738C8DBQ36848233-8D6952CE-EB08-4772-8584-6D291CEE3BF7Q37631608-701ED012-C4CE-49CB-8F62-02079791909DQ40127553-2355BA28-7B7D-40CA-B30B-5434F39847D1Q40616341-EB02C323-B62C-4489-AD77-1C5A26FF7854Q41204978-1FC209AF-4224-4C6B-AB42-8E39372693D2Q42210883-81DDDD28-9BB8-482A-B3FB-50B34D40A015Q42243752-F40DE534-A627-4E3A-A051-10E827D9FDD9Q42263092-E69B69F9-F07A-4F7F-82AF-A840C2D9E581Q42282623-1F6AB19E-534F-454C-BAE3-174E3AEE0C4CQ42618850-034B6442-06F8-4C01-81C2-2D05FB4B9B6FQ42984105-7291BF77-4FBB-4D5A-8616-B023AC23AE8FQ42996175-6D244D0E-2882-42A6-A524-2514375E63B8Q45323672-1EC53F25-99D0-484E-B3ED-51812FFF47E4Q45324292-7DCE90B1-83C5-48D0-834D-389F8E8630F3Q54250864-16D3B0D8-B8A6-4DF9-9B42-1823E0CF15E1Q54505505-2C6C46E0-782F-44BD-9EAA-F864D0DBA23CQ55224660-962C09C4-B003-4FC4-B5AF-2C85B3D82C66
P50
description
Pools onderzoekster
@nl
polska biolog
@pl
researcher
@en
հետազոտող
@hy
name
A Pawełczyk
@ast
A Pawełczyk
@en
A Pawełczyk
@es
A Pawełczyk
@nl
Agnieszka Pawełczyk
@ca
Agnieszka Pawełczyk
@cs
Agnieszka Pawełczyk
@gl
Agnieszka Pawełczyk
@hr
Agnieszka Pawełczyk
@hsb
Agnieszka Pawełczyk
@it
type
label
A Pawełczyk
@ast
A Pawełczyk
@en
A Pawełczyk
@es
A Pawełczyk
@nl
Agnieszka Pawełczyk
@ca
Agnieszka Pawełczyk
@cs
Agnieszka Pawełczyk
@gl
Agnieszka Pawełczyk
@hr
Agnieszka Pawełczyk
@hsb
Agnieszka Pawełczyk
@it
prefLabel
A Pawełczyk
@ast
A Pawełczyk
@en
A Pawełczyk
@es
A Pawełczyk
@nl
Agnieszka Pawełczyk
@ca
Agnieszka Pawełczyk
@cs
Agnieszka Pawełczyk
@gl
Agnieszka Pawełczyk
@hr
Agnieszka Pawełczyk
@hsb
Agnieszka Pawełczyk
@it
P106
P1153
57196551835
P1412
P1559
Agnieszka Pawełczyk
@pl
P21
P214
3590147907506779210001
P27
P31
P3124
P496
0000-0001-9336-8258